AMTI AccuGait-Optimized force plates

The Food and Drug Administration is forecasting the procurement of AMTI AccuGait-Optimized force plates to enhance data collection capabilities within an expanded laboratory space. These specialized plates provide high temporal resolution of footfalls and distributed force and moments during various ambulatory tasks, such as walking, turning, and shifting weight. By capturing high-resolution movement data under free-living conditions, the equipment will serve as ground truth sensors to validate and derive movement-focused digital endpoints for various sensor-based digital health technologies. This opportunity is managed by the Food and Drug Administration, with the Cdrh Acquisition Liaison serving as the primary program point of contact. While specific solicitation details, NAICS codes, and set-aside designations have not yet been determined, the project is currently listed as a forecast to notify potential providers of the agency's intent to acquire this specialized gait analysis technology.